⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

August 1, 2024Open Access

Supplementary Figure S7 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy

Pei Y. Teo Youngrock Jung David H. Quach Joanna Koh Richard Ong Angeline Goh Alrina Tan Chee H. Ng Cheah C. Seh Kar Wai Tan Ivan D. Horak Lionel Low

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Supplementary Figure S7. Manufacturing of Allo-T cells which are pre-primed alloreactive ‘recipient’ cells that recognize and kill ‘donor’ cells. A, Manufacturing timeline for the generation of Allo-T. B, CD30 expression of CD30KO Allo-T cells determined by the staining of CD30 with two different antibody clones, BY88 and BerH8, and flow cytometry analysis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Teo et al. (2024) studied this question.

synapsesocial.com/papers/68e5e0e0b6db643587574f49 https://doi.org/10.1158/2326-6066.26422769

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S7 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024
2Supplementary Figure S8 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024
3Supplementary Figure S8 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024
4Supplementary Figure S11 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024
5Supplementary Figure S11 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024
6Supplementary Figure S13 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024
7Supplementary Figure S13 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024
8Supplementary Figure S14 from Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy2024